MedTrace Logo

Peripheral Nerve Stimulation Registry for Intractable Migraine Headache

NCT02227758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2019-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the long-term safety and performance of neurostimulation for the treatment of intractable chronic migraine as well as to detect infrequent complications or problems only apparent in "real-world" practice

Conditions

  • Intractable Chronic Migraine

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Belgium
  • Germany
  • Luxembourg
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227758 on ClinicalTrials.gov